Cargando…

Characterization of Cortisol Secretion Rate in Secondary Adrenal Insufficiency

CONTEXT: In secondary adrenal insufficiency (SAI), chronic deficiency of adrenocorticotropin (ACTH) is believed to result in secondary changes in adrenocortical function, causing an altered dose-response relationship between ACTH concentration and cortisol secretion rate (CSR). OBJECTIVE: We sought...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorin, Richard I., Qiao, Zhi George, Bouchonville, Matthew, Qualls, Clifford R., Schrader, Ronald M., Urban, Frank K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686692/
https://www.ncbi.nlm.nih.gov/pubmed/29264545
http://dx.doi.org/10.1210/js.2017-00198
_version_ 1783278826377183232
author Dorin, Richard I.
Qiao, Zhi George
Bouchonville, Matthew
Qualls, Clifford R.
Schrader, Ronald M.
Urban, Frank K.
author_facet Dorin, Richard I.
Qiao, Zhi George
Bouchonville, Matthew
Qualls, Clifford R.
Schrader, Ronald M.
Urban, Frank K.
author_sort Dorin, Richard I.
collection PubMed
description CONTEXT: In secondary adrenal insufficiency (SAI), chronic deficiency of adrenocorticotropin (ACTH) is believed to result in secondary changes in adrenocortical function, causing an altered dose-response relationship between ACTH concentration and cortisol secretion rate (CSR). OBJECTIVE: We sought to characterize maximal cortisol secretion rate (CSR(max)) and free cortisol half-life in patients with SAI, compare results with those of age-matched healthy controls, and examine the influence of predictor variables on ACTH-stimulated cortisol concentrations. DESIGN: CSR(max) was estimated from ACTH(1-24) (250 μg)(–)stimulated cortisol time-concentration data. Estimates for CSR(max) and free cortisol half-life were obtained for both dexamethasone (DEX) and placebo pretreatment conditions for all subjects. SETTING: Single academic medical center. PATIENTS: Patients with SAI (n = 10) compared with age-matched healthy controls (n = 21). INTERVENTIONS: The order of DEX vs placebo pretreatment was randomized and double-blind. Cortisol concentrations were obtained at baseline and at intervals for 120 minutes after ACTH(1-24). MAIN OUTCOME MEASURES: CSR(max) and free cortisol half-life were obtained by numerical modeling analysis. Predictors of stimulated cortisol concentrations were evaluated using a multivariate model. RESULTS: CSR(max) was significantly (P < 0.001) reduced in patients with SAI compared with controls for both placebo (0.17 ± 0.09 vs 0.46 ± 0.14 nM/s) and DEX (0.18 ± 0.13 vs 0.43 ± 0.13 nM/s) conditions. Significant predictors of ACTH(1-24–)stimulated total cortisol concentrations included CSR(max), free cortisol half-life, and baseline total cortisol, corticosteroid-binding globulin, and albumin concentrations (all P < 0.05). CONCLUSIONS: Our finding of significantly decreased CSR(max) confirms that SAI is associated with alterations in the CSR-ACTH dose-response curve. Decreased CSR(max) contributes importantly to the laboratory diagnosis of SAI.
format Online
Article
Text
id pubmed-5686692
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-56866922017-12-20 Characterization of Cortisol Secretion Rate in Secondary Adrenal Insufficiency Dorin, Richard I. Qiao, Zhi George Bouchonville, Matthew Qualls, Clifford R. Schrader, Ronald M. Urban, Frank K. J Endocr Soc Clinical Research Articles CONTEXT: In secondary adrenal insufficiency (SAI), chronic deficiency of adrenocorticotropin (ACTH) is believed to result in secondary changes in adrenocortical function, causing an altered dose-response relationship between ACTH concentration and cortisol secretion rate (CSR). OBJECTIVE: We sought to characterize maximal cortisol secretion rate (CSR(max)) and free cortisol half-life in patients with SAI, compare results with those of age-matched healthy controls, and examine the influence of predictor variables on ACTH-stimulated cortisol concentrations. DESIGN: CSR(max) was estimated from ACTH(1-24) (250 μg)(–)stimulated cortisol time-concentration data. Estimates for CSR(max) and free cortisol half-life were obtained for both dexamethasone (DEX) and placebo pretreatment conditions for all subjects. SETTING: Single academic medical center. PATIENTS: Patients with SAI (n = 10) compared with age-matched healthy controls (n = 21). INTERVENTIONS: The order of DEX vs placebo pretreatment was randomized and double-blind. Cortisol concentrations were obtained at baseline and at intervals for 120 minutes after ACTH(1-24). MAIN OUTCOME MEASURES: CSR(max) and free cortisol half-life were obtained by numerical modeling analysis. Predictors of stimulated cortisol concentrations were evaluated using a multivariate model. RESULTS: CSR(max) was significantly (P < 0.001) reduced in patients with SAI compared with controls for both placebo (0.17 ± 0.09 vs 0.46 ± 0.14 nM/s) and DEX (0.18 ± 0.13 vs 0.43 ± 0.13 nM/s) conditions. Significant predictors of ACTH(1-24–)stimulated total cortisol concentrations included CSR(max), free cortisol half-life, and baseline total cortisol, corticosteroid-binding globulin, and albumin concentrations (all P < 0.05). CONCLUSIONS: Our finding of significantly decreased CSR(max) confirms that SAI is associated with alterations in the CSR-ACTH dose-response curve. Decreased CSR(max) contributes importantly to the laboratory diagnosis of SAI. Endocrine Society 2017-06-01 /pmc/articles/PMC5686692/ /pubmed/29264545 http://dx.doi.org/10.1210/js.2017-00198 Text en Copyright © 2017 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Clinical Research Articles
Dorin, Richard I.
Qiao, Zhi George
Bouchonville, Matthew
Qualls, Clifford R.
Schrader, Ronald M.
Urban, Frank K.
Characterization of Cortisol Secretion Rate in Secondary Adrenal Insufficiency
title Characterization of Cortisol Secretion Rate in Secondary Adrenal Insufficiency
title_full Characterization of Cortisol Secretion Rate in Secondary Adrenal Insufficiency
title_fullStr Characterization of Cortisol Secretion Rate in Secondary Adrenal Insufficiency
title_full_unstemmed Characterization of Cortisol Secretion Rate in Secondary Adrenal Insufficiency
title_short Characterization of Cortisol Secretion Rate in Secondary Adrenal Insufficiency
title_sort characterization of cortisol secretion rate in secondary adrenal insufficiency
topic Clinical Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686692/
https://www.ncbi.nlm.nih.gov/pubmed/29264545
http://dx.doi.org/10.1210/js.2017-00198
work_keys_str_mv AT dorinrichardi characterizationofcortisolsecretionrateinsecondaryadrenalinsufficiency
AT qiaozhigeorge characterizationofcortisolsecretionrateinsecondaryadrenalinsufficiency
AT bouchonvillematthew characterizationofcortisolsecretionrateinsecondaryadrenalinsufficiency
AT quallscliffordr characterizationofcortisolsecretionrateinsecondaryadrenalinsufficiency
AT schraderronaldm characterizationofcortisolsecretionrateinsecondaryadrenalinsufficiency
AT urbanfrankk characterizationofcortisolsecretionrateinsecondaryadrenalinsufficiency